Target-oriented therapy: Emerging drugs for atopic dermatitis

@article{Lauffer2016TargetorientedTE,
  title={Target-oriented therapy: Emerging drugs for atopic dermatitis},
  author={F. Lauffer and J. Ring},
  journal={Expert Opinion on Emerging Drugs},
  year={2016},
  volume={21},
  pages={81 - 89}
}
ABSTRACT Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a life-time prevalence of 10 – 20% in western countries. Patients suffer from stigmatizing eczematous skin lesions, persisting itch and sleep disorders. Starting usually in early childhood the course of AD is heterogeneous. While most frequently AD disappears before adolescence, about 30% of patients show a chronic persisting course. There is an urgent need for new therapeutic options as until now… Expand
Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
Atopic dermatitis: a review of evolving targeted therapies
Novel Therapeutic Approaches to Atopic Dermatitis
Systemic Treatment of Adult Atopic Dermatitis: A Review
Current and emerging topical therapies for atopic dermatitis.
Molecular signatures order the potency of topically applied anti‐inflammatory drugs in patients with atopic dermatitis
The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus
...
1
2
3
...

References

SHOWING 1-10 OF 88 REFERENCES
Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
Immunology of atopic eczema: overcoming the Th1/Th2 paradigm
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
New insights into the epidemiology of childhood atopic dermatitis
Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab.
Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy
...
1
2
3
4
5
...